-
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Q4 2025 Earnings Call Transcript
28 Feb 2026 13:21 GMT
… products, and other advanced drug-device combinations. As a … high-value Affordable Medicines launches in Amneal Pharmaceuticals, Inc.’s history … of treatment has been immediate-release carbidopa/levodopa, a … we received from the FDA in the last couple …
-
EMA Backs Continuous Infusion Levodopa for Parkinson’s
27 Feb 2026 17:56 GMT
… stable plasma drug levels and addresses the limitations of oral medications.
A … effects allowing levodopa to be used more effectively.
The treatment is administered … a retired National Health Service doctor. A well-known TV and …
-
Human medicines European public assessment report (EPAR): Onerji, levodopa,carbidopa, Status: Opinion
27 Feb 2026 15:06 GMT
… for the medicinal product Onerji, intended for the treatment of … Onerji are levodopa and carbidopa, anti-Parkinson drugs (ATC code: … Onerji, carbidopa, helps levodopa work better by stopping … its ability to increase levodopa plasma concentrations and provide …
-
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 February 2026
27 Feb 2026 14:00 GMT
… opinion for Onerji (levodopa / carbidopa), for the treatment of adults with … by Trypanosoma brucei gambiense. This medicine simplifies treatment of first- and second … Pharmaceuticals (iloperidone) received a negative opinion from the CHMP for the treatment …
-
Misdiagnosed Parkinson's patient regains life after NPH treatment
27 Feb 2026 03:10 GMT
… hadn't responded to levodopa concerned Dr. Schaffert. … a randomized controlled clinical trial involving multiple sites in … understanding its full effects, doctors hope to determine which … the medical community, so others can get the treatment they …
-
Serina Therapeutics Announces Dosing of First Patient in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s Disease
24 Feb 2026 21:05 GMT
… a clinical-stage biotechnology company advancing drug candidates enabled by … to support efficient trial execution. The Company … reduce the severity of levodopa-related motor complications ( … completion dates for clinical trials, regulatory submission dates, …
-
Supernus Announces Record Fourth Quarter and Full Year 2025 Financial Results
24 Feb 2026 21:05 GMT
… an adjunctive treatment to the current baseline antidepressant therapy, … About Supernus Pharmaceuticals, Inc. Supernus Pharmaceuticals is a … (PD) patients receiving levodopa-based therapy, hypomobility … 's clinical trials, and projected expenditures; …
-
After CHMP nod, Moderna CEO applauds EU's 'rigorous scientific review'
28 Feb 2026 01:42 GMT
…
The Committee for Medicinal Products for Human Use … of the successful trial backing the submission … subcutaneous infusion of liquid levodopa and carbidopa, for … Pharmaceuticals’ Rett syndrome drug Daybu, questioning its efficacy. The FDA approved the treatment …
-
Effects of Different STN-DBS Programming Strategies on Non-Motor Symptoms in Parkinson’s Disease: A Retrospective Controlled Study
25 Feb 2026 16:32 GMT
… frequency programming.
Levodopa equivalent daily dose … medication allowing optimization of antidepressant regimens; (4) psychological benefits of successful surgical treatment … crossover trials comparing frequency- … randomized clinical trial. Mov Disord. …
-
McGill Biodesign pushes the boundaries of competitive bioengineering and peer collaboration
24 Feb 2026 17:36 GMT
… developing a monitoring system for levodopa, a medication used as a dopamine …